Carroll Investors’s Zoetis ZTS Stock Holding History

Carroll Investors’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,233	Closed	-$205K	–	39
2023 Q1	$205K	Buy	+1,233	New	+$202K	0.17%	39

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carroll Investors's ZTS Position: Q2 2023 in Review

Carroll Investors sold out of Zoetis (ZTS) in Q2 2023, closing a stake of 1,233 shares — an estimated $205K sold.

Carroll Investors first reported a position in ZTS in Q1 2023 and held it in 1 quarter. The position peaked at $205K in Q1 2023. 1,627 funds tracked by Wall St. Rank hold ZTS as of Q2 2023.

Carroll Investors reported no remaining Zoetis position as of Q2 2023 after selling out during the quarter.
Carroll Investors sold 1,233 Zoetis shares in Q2 2023, an estimated $205K.
Carroll Investors first reported a position in Zoetis in Q1 2023 and held it in 1 quarter.
Carroll Investors's Zoetis position peaked at $205K in Q1 2023.
1,627 funds tracked by Wall St. Rank held Zoetis as of Q2 2023.

Based on Carroll Investors's 13F filing for Q2 2023, filed 9 Aug 2023.